NCT05668078

Brief Summary

The goal of this trial is to evaluate the impact of different testing strategies with Rapid Antigen Testing (RAT) on reduction of school absences. RATs are relatively inexpensive, fast, and can be performed at the point of care. Provision of testing in schools will allow rapid identification and isolation of individuals infected with Covid-19. This will likely reduce COVID-19 transmission, as well as allow symptomatic COVID-19 negative students to return to classroom, avoiding the 10-days isolation period. If proven successful, the lessons from this study can be translated to schools in similar settings. While several testing strategies have been proposed and evaluated in developed countries, no studies have evaluated the role of testing for safe operation of schools or reducing absenteeism in developing country contexts.The lessons learned from this study is likely to inform government policy regarding the provision of testing in school. Study design: Cluster randomized trial School types: Three types based on testing:

  • Intervention school-1: Test all symptomatic students, teachers, and support staff ; and track symptoms and absenteeism
  • Intervention school-2: Test all students, teachers, and support staff every 3 days, irrespective of symptoms (also test whenever develops symptoms) and track symptoms and absenteeism
  • Control school: Only track the students for symptom notification and absenteeism

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,141

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started May 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 18, 2022

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 30, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 30, 2022

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

November 25, 2022

Completed
1 month until next milestone

First Posted

Study publicly available on registry

December 29, 2022

Completed
Last Updated

December 29, 2022

Status Verified

December 1, 2022

Enrollment Period

2 months

First QC Date

November 25, 2022

Last Update Submit

December 25, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • The number of days absent

    Daily data on school absence was collected prospectively from the school authorities and the cause of absence was collected from the students.

    10 Weeks

Secondary Outcomes (1)

  • COVID-19 positivity

    10 Weeks

Study Arms (3)

School-type 1, intervention school-1

EXPERIMENTAL

We will test all symptomatic students, teachers, and support staff ; and track students symptoms and absenteeism

Diagnostic Test: Rapid Antigen Testing (RAT) for COVID-19

School-type 2, intervention school-2

EXPERIMENTAL

We will test all students, teachers, and support staff every 3 days, irrespective of symptoms (also test whenever develops symptoms) and track students symptoms and absenteeism

Diagnostic Test: Rapid Antigen Testing (RAT) for COVID-19

In School-type 3, control school

EXPERIMENTAL

We will not do any test, only track the students for symptom notification and absenteeism

Diagnostic Test: Rapid Antigen Testing (RAT) for COVID-19

Interventions

COVID-19 RAT intervention done among the school students to see if RAT test can play a role in reducing absenteeism. School type-1-only for symptomatic participants, School type-2-Serial testing at three days interval for all participants and School type-3 got no testing.

In School-type 3, control schoolSchool-type 1, intervention school-1School-type 2, intervention school-2

Eligibility Criteria

Age13 Years - 19 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • A day school (not residential), with at least 50 students per classroom that follows the national curriculum in either Bangla or English instruction
  • Students of class Nine, Ten and Eight
  • Providing written consent for participation (both student and Guardian)

You may not qualify if:

  • Not providing written consent for participation (both student and Guardian)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Icddr,B

Dhaka, 1212, Bangladesh

Location

Study Officials

  • Arifa Nazneen, MBBS, MPH

    International Centre for Diarrhoeal Disease Research, Bangladesh

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 25, 2022

First Posted

December 29, 2022

Study Start

May 18, 2022

Primary Completion

July 30, 2022

Study Completion

July 30, 2022

Last Updated

December 29, 2022

Record last verified: 2022-12

Data Sharing

IPD Sharing
Will not share

Locations